pd 153035 has been researched along with su 6656 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Tzeng, DW; Wang, CY; Wang, YT; Yang, JL | 1 |
2 other study(ies) available for pd 153035 and su 6656
Article | Year |
---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
Topics: Blotting, Western; Butyrates; Cell Line, Tumor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Genes, ras; Humans; Immunoprecipitation; Indoles; Organometallic Compounds; Phenols; Phosphorylation; Protein Kinase C-alpha; Quinazolines; raf Kinases; Receptors, Platelet-Derived Growth Factor; src-Family Kinases; Sulfonamides; Transfection | 2009 |